Search

everythinglearnresearchcommunity

for

Search:↓

A specific gene mutation causes different hair defects in Indian monilethrix families.

A 3-year-old girl with skin mast cell buildup and congenital baldness improved with treatment, suggesting a rare link between these conditions.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Significant hair regrowth doesn't always mean complete hair recovery in alopecia areata.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

A woman experienced severe symptoms, including hair loss, after a COVID-19 vaccine, suggesting a possible autoimmune reaction.

Hair India 2012 was a successful international event focused on combating fake trichology practices and discussing various hair health topics.

The polyherbal hair oil with flaxseed promotes hair growth and health.

The polyherbal hair oil with flaxseed promotes hair growth and health.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Ayurveda suggests using herbal remedies and balancing body tissues for healthy hair.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Ferulic acid helps stabilize vitamins C and E for better skin protection from the sun, certain compounds may promote hair growth, atopic dermatitis patients have lower skin defense molecules, older men are more likely to get a type of skin cancer, and a substance called relaxin may prevent age-related skin thickening.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.

Psoriasis is a common skin disorder caused by immune system issues, treatable with various therapies.

Hormonal differences affect male pattern baldness.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Scleroderma patients have lower hair miR-29a levels.

MSC-derived EVs show promise for therapy, but production and understanding need improvement.

Capparis decidua fruit may help break down blood clots, but more research is needed.